Emanuelle Bellaguarda, MD, is a gastroenterologist specializing in inflammatory bowel diseases and serves as Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Northwestern University Feinberg School of Medicine. She is an attending physician at Northwestern Memorial Hospital, a member of Northwestern Medical Group, and is affiliated with the Northwestern University Clinical and Translational Sciences Institute. Dr. Bellaguarda’s clinical focus includes comprehensive care for complex inflammatory bowel conditions, immune-mediated gastrointestinal toxicities, and personalized treatment optimization, including microbiome-based therapies and reproductive health counseling. Her research interests center on noninvasive biomarker development, precision therapeutic optimization, and the microbiome’s role in gastrointestinal health and translational therapeutics. At Northwestern, she is Program Director of the Advanced Inflammatory Bowel Disease Fellowship, Director of the Fecal Microbiota Transplant Program, and Lead of the Immune-Mediated Colitis Toxicity Service. She has received the Department of Medicine Teaching Award and serves in advisory roles with the Crohn’s & Colitis Foundation as well as on scientific and medical advisory boards for academic-industry collaborations. Dr. Bellaguarda earned her medical degree from the Federal University of Ceará/Universidade Estadual do Ceará in Brazil, completed her internal medicine residency at Boston University Medical Center, her fellowship in gastroenterology, hepatology, and nutrition at the University of Chicago Medical Center, and advanced subspecialty fellowship training in inflammatory bowel disease at McGaw Medical Center of Northwestern University Feinberg School of Medicine.
Associate Professor
Medical School
2000 – 2006
Residency
2008 – 2011
Fellowship
2011 – 2014